Published in AIDS Weekly, September 11th, 1995
The vaccine is being developed by a research team led by David B. Weiner of the University of Pennsylvania, Philadelphia, in collaboration with Apollon Inc., Malvern, Pennsylvania. Weiner's group in 1995 received a four-year, $4.2 million grant from the U.S. National Institute of Allergy and Infectious Diseases (NIAID) to develop naked DNA for use as an AIDS therapy.
Weiner recently reported that one of four monkeys inoculated with the vaccine remained uninfected after receiving a massive dose of an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.